about
CD4-specific designed ankyrin repeat proteins are novel potent HIV entry inhibitors with unique characteristicsEfficacy of Carraguard-based microbicides in vivo despite variable in vitro activityManipulation of dendritic cell function by virusesMobilization of HIV spread by diaphanous 2 dependent filopodia in infected dendritic cellsThe NRTIs lamivudine, stavudine and zidovudine have reduced HIV-1 inhibitory activity in astrocytesDynamic imaging of the hepatitis C virus NS5A protein during a productive infection.TNF-alpha induces macroautophagy and regulates MHC class II expression in human skeletal muscle cells.The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages.HIV-1 entry and trans-infection of astrocytes involves CD81 vesicles.The C-type Lectin Langerin Functions as a Receptor for Attachment and Infectious Entry of Influenza A VirusSlamming the door on unwanted guests: why preemptive strikes at the mucosa may be the best strategy against HIV.A fusion inhibitor prevents spread of immunodeficiency viruses, but not activation of virus-specific T cells, by dendritic cells.Novel RNA Duplex Locks HIV-1 in a Latent State via Chromatin-mediated Transcriptional Silencing.Double-stranded RNA analog poly(I:C) inhibits human immunodeficiency virus amplification in dendritic cells via type I interferon-mediated activation of APOBEC3G.Oligomerization of the macrophage mannose receptor enhances gp120-mediated binding of HIV-1.HIV-1-infected dendritic cells show 2 phases of gene expression changes, with lysosomal enzyme activity decreased during the second phaseThe feasibility of incorporating Vpx into lentiviral gene therapy vectors.HIV infection is influenced by dynamin at 3 independent points in the viral life cycle.Marked differences in the structures and protein associations of lymphocyte and monocyte CD4: resolution of a novel CD4 isoform.Inhibition of two temporal phases of HIV-1 transfer from primary Langerhans cells to T cells: the role of langerin.HIV infection of dendritic cells.HIV gp120 receptors on human dendritic cells.Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells.HIV-1 infection of human macrophages directly induces viperin which inhibits viral production.Revising the Role of Myeloid cells in HIV Pathogenesis.All-Round Manipulation of the Actin Cytoskeleton by HIV.Blocking of HIV entry through CD44-hyaluronic acid interactions.Analysis and dissociation of anti-HIV effects of shRNA to CCR5 and the fusion inhibitor C46.Obituary: Remembering Professor David Cooper.Kinetics of HIV-1 capsid uncoating revealed by single-molecule analysis.CD4 is expressed by epidermal Langerhans' cells predominantly as covalent dimersResolution of de novo HIV production and trafficking in immature dendritic cellsCarrageenan/MIV-150 (PC-815), a combination microbicideDelivery of gene therapy to resting immune cells for an HIV cure
P50
Q21090521-DD120644-8221-497F-84D2-298ED26C04E9Q21562543-AA840812-70F6-4C6A-A4A4-68BBD41FC463Q21710678-B3B5F201-4BB9-433A-8551-CBA280974E18Q27345158-B13B7F34-3DC3-48B5-9466-AE6FA6292ADEQ28486204-F3198D67-D1E8-482D-81CA-B19F2EAEC936Q30576516-13DBFC79-E63E-473E-811D-D1B2C651B23DQ34537114-FABFA7EF-C697-4E90-A02A-6F32F0E0AD51Q35040074-5BEB04D0-9A8D-45A8-8C96-28A5AB71A297Q35109157-518AD751-791A-4ABC-BA79-36F263B38E19Q36433824-70DA1234-6CF8-4A05-B322-55DB24249259Q36565463-CFEF3DB1-A9B4-492B-AD2D-39201716E235Q36673272-EE85E448-1B5A-4EE1-AC48-BAB2F08BDFBCQ36939741-D8808CB9-C3C9-40DC-8A1D-41E2C19C8EE5Q37033387-198F55CC-E81E-438B-B571-746DB2D266DBQ37160836-02FE3CC7-BFEA-4944-A608-AB6A9D4D93F6Q37262510-695CFEF2-DF25-444C-A669-100E67D7EAA7Q37350713-12A60FD3-01D0-4F9D-BE30-11FADB94828EQ40283606-9646AED3-ECD9-4469-B7C2-7DAC385ABE67Q40308237-F90A6BE7-E078-4BEC-87D7-09DB00A77E70Q42203272-87A112A2-665A-43BF-B83E-FC6854A86767Q42259828-6C313DCA-CC55-42AE-8AFE-2B5106293856Q43757337-86A490AD-FE7A-4600-9A2B-07375EA86966Q44664018-CF87967C-4C83-46F6-89CE-C52BDC569057Q44683563-CBA46F04-11B3-423C-AEB0-1D1CDCC2BADCQ45252370-084621A2-F001-4B4A-AD13-E95517059C37Q48104489-6CEE3CED-E95A-4C94-B231-455DE5A9C29CQ51822253-AF274944-95DB-4B7D-8F23-148EC652E87DQ54253744-F52A3942-7FD7-4D52-B030-1D5CC7D31ABDQ55385597-1ED8C52D-1D9F-42C2-8F0E-CA62B2C929A6Q55621177-2946FFD2-72E9-41FE-BB27-E3A650E8DA97Q57076532-6A5616D5-8186-4A55-8BB2-E57994FB5EE6Q80146470-A8490A58-AAF1-41BD-9790-10F0C166B17AQ80149044-C03A5416-D745-488A-9468-B6AF6F8641A9Q90876834-6341C5C6-B20D-44E3-9CAA-3B607416466F
P50
description
Forscher
@de
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
研究者
@zh
name
Stuart G Turville
@ast
Stuart G Turville
@en
Stuart G Turville
@es
Stuart G Turville
@nl
type
label
Stuart G Turville
@ast
Stuart G Turville
@en
Stuart G Turville
@es
Stuart G Turville
@nl
prefLabel
Stuart G Turville
@ast
Stuart G Turville
@en
Stuart G Turville
@es
Stuart G Turville
@nl
P108
P106
P108
P1153
6507720820
P31
P496
0000-0003-1918-5343